Literature DB >> 22103711

Emerging roles of anacardic acid and its derivatives: a pharmacological overview.

Mahadevappa Hemshekhar1, Martin Sebastin Santhosh, Kempaiah Kemparaju, Kesturu S Girish.   

Abstract

Anacardic acid (AA) is a bioactive phytochemical found in nutshell of Anacardium occidentale. Chemically, it is a mixture of several closely related organic compounds, each consisting of salicylic acid substituted with an alkyl chain. The traditional Ayurveda depicts nutshell oil as a medicinal remedy for alexeritic, amebicidal, gingivitis, malaria and syphilitic ulcers. However, the enduring research and emerging evidence suggests that AA could be a potent target molecule with bactericide, fungicide, insecticide, anti-termite and molluscicide properties and as a therapeutic agent in the treatment of the most serious pathophysiological disorders like cancer, oxidative damage, inflammation and obesity. Furthermore, AA was found to be a common inhibitor of several clinically targeted enzymes such as NFκB kinase, histone acetyltransferase (HATs), lipoxygenase (LOX-1), xanthine oxidase, tyrosinase and ureases. In view of this, we have made an effort to summarize the ongoing research on the therapeutical role of AA and its derivatives. The current MiniReview sheds light on the pharmacological applications, toxicity and allergic responses associated with AA and its derivatives. Although the available records are promising, much more detailed investigations into the therapeutical properties, particularly the anti-cancer and anti-inflammatory activities, are urgently needed. We hope the present MiniReview will attract and encourage further research on elucidating and appreciating the possible curative properties of AA and its derivatives in the management of multifactorial diseases.
© 2011 The Authors. Basic & Clinical Pharmacology & Toxicology © 2011 Nordic Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103711     DOI: 10.1111/j.1742-7843.2011.00833.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  49 in total

1.  Chromatin modifications sequentially enhance ErbB2 expression in ErbB2-positive breast cancers.

Authors:  Sathish Kumar Mungamuri; William Murk; Luca Grumolato; Emily Bernstein; Stuart A Aaronson
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

2.  Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation.

Authors:  Marion Dubuissez; Ingrid Loison; Sonia Paget; Han Vorng; Saliha Ait-Yahia; Olivier Rohr; Anne Tsicopoulos; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2016-06-15       Impact factor: 4.272

Review 3.  Cellular analysis of the action of epigenetic drugs and probes.

Authors:  Mirjam Hau; Fides Zenk; A Ganesan; Nicola Iovino; Manfred Jung
Journal:  Epigenetics       Date:  2017-01-10       Impact factor: 4.528

4.  Anacardic acid, interleukin-33, and the quest for remyelination.

Authors:  Murali Ramanathan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-03       Impact factor: 11.205

5.  Ehrlichia chaffeensis exploits host SUMOylation pathways to mediate effector-host interactions and promote intracellular survival.

Authors:  Paige Selvy Dunphy; Tian Luo; Jere W McBride
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

6.  Histone acetylation inhibitors promote axon growth in adult dorsal root ganglia neurons.

Authors:  Shen Lin; Kutaiba Nazif; Alexander Smith; Peter W Baas; George M Smith
Journal:  J Neurosci Res       Date:  2015-02-20       Impact factor: 4.164

7.  Exhaustive valorization of cashew nut shell waste as a potential bioresource material.

Authors:  James Nyirenda; Kadango Zombe; George Kalaba; Chipo Siabbamba; Inyambo Mukela
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

8.  Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling.

Authors:  Jing Tan; Binghai Chen; Leye He; Yuxin Tang; Zhiqiang Jiang; Guangmin Yin; Jinrong Wang; Xianzhen Jiang
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

Review 9.  Targeting the histone orthography of cancer: drugs for writers, erasers and readers.

Authors:  Laia Simó-Riudalbas; Manel Esteller
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 10.  Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.

Authors:  Anne Yuqing Yang; Hyuck Kim; Wenji Li; Ah-Ng Tony Kong
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.